{
    "Trade/Device Name(s)": [
        "RapidSense Drugs of Abuse Methamphetamine (MET) 1000 Device",
        "RapidSense Drugs of Abuse Methamphetamine (MET) 1000 Device, model 900-0050"
    ],
    "Submitter Information": "QuantRx Biomedical Corporation",
    "510(k) Number": "K080455",
    "Predicate Device Reference 510(k) Number(s)": [
        "K011672"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LAF"
    ],
    "Summary Letter Date": "December 31, 2008",
    "Summary Letter Received Date": "December 24, 2008",
    "Submission Date": "December 23, 2008",
    "Regulation Number(s)": [
        "21 CFR 862.3610"
    ],
    "Regulation Name(s)": [
        "Methamphetamine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Methamphetamine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow competitive immunoassay"
    ],
    "Methodologies": [
        "Competitive immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Device"
    ],
    "Document Summary": "FDA 510(k) summary for RapidSense Methamphetamine lateral flow immunoassay device for qualitative detection of methamphetamine in urine",
    "Indications for Use Summary": "Qualitative detection of methamphetamine in human urine at 1000 ng/mL cutoff using a lateral flow competitive immunoassay, for professional laboratory use by healthcare professionals",
    "fda_folder": "Toxicology"
}